SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Ingrevia raises Rs 150 crore through Commercial Papers

18 Feb 2022 Evaluate

Jubilant Ingrevia has raised Rs 150 crore through the issuance of Commercial Papers (‘CPs’) on February 17, 2022. Date of maturity of said Commercial Papers will be March 25, 2022. Tenure of the instrument is for 36 days. The company has issued Commercial Papers at 4.15% per annum. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 150 crore.

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.

Jubilant Ingrevia Share Price

689.95 30.55 (4.63%)
22-Apr-2026 12:32 View Price Chart
Peers
Company Name CMP
BASF India 3725.15
Tata Chemicals 709.05
SRF 2497.90
Pidilite Inds. 1407.30
Deepak Nitrite 1719.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×